Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre

December 8, 2013 updated by: National University Hospital, Singapore
The investigators hypothesise that the research data will enable them to elucidate local clinical practices with regard to breast cancer care and enable them to extrpolate the data to improved local clinical care for their patients through self-regulation and audit.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119074
        • Recruiting
        • National University Hospital
        • Principal Investigator:
          • Sing Huang Tan, MBBS
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

To retropsectively review the NCIS registry of females diagnosed with breast cancer in years 2002 to 2008 with regards to clinical quality indicators as published by the European Sociaty of Breast Cancer Oncologists (Eur J Can 2010; 46:2344-2356). We will extract data from a pre-existing breast cancer registry which belongs to NCIS, looking at data which includes the following:(1) Completeness of clinical and imaging diagnostic work-up(2) Completeness of prognostic and predictive characterization(3) Multidisciplinary discussion(4) Appropriate surgical approach(5) Appropriate post-operative radiation(6) Avoidance of over-treatment(7) Appropraiet hormonal therapy(8) Appropriate chemotherapy and other medical therapy(9) Staging, counselling, follow-up and rehabilitative procedures

Description

Inclusion Criteria:

  • Female
  • 21 years old

Exclusion Criteria:

No patient involved

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
No treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Quality of care at NCIS using indicators
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
The trends and variations in quality of care indices over a period of years
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Anticipated)

December 1, 2013

Study Registration Dates

First Submitted

October 31, 2012

First Submitted That Met QC Criteria

May 30, 2013

First Posted (Estimate)

May 31, 2013

Study Record Updates

Last Update Posted (Estimate)

December 10, 2013

Last Update Submitted That Met QC Criteria

December 8, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • BR08/30/10

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

3
Subscribe